Does PALBOCICLIB Cause Chronic kidney disease? 110 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 110 reports of Chronic kidney disease have been filed in association with PALBOCICLIB (Ibrance). This represents 0.1% of all adverse event reports for PALBOCICLIB.
110
Reports of Chronic kidney disease with PALBOCICLIB
0.1%
of all PALBOCICLIB reports
10
Deaths
35
Hospitalizations
How Dangerous Is Chronic kidney disease From PALBOCICLIB?
Of the 110 reports, 10 (9.1%) resulted in death, 35 (31.8%) required hospitalization, and 19 (17.3%) were considered life-threatening.
Is Chronic kidney disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 110 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Chronic kidney disease?
OMEPRAZOLE (35,759)
ESOMEPRAZOLE (35,281)
LANSOPRAZOLE (32,517)
PANTOPRAZOLE (28,127)
DEXLANSOPRAZOLE (15,973)
EMTRICITABINE\TENOFOVIR DISOPROXIL (10,248)
TENOFOVIR DISOPROXIL (7,230)
EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (5,861)
RABEPRAZOLE (4,773)
ESOMEPRAZOLE\NAPROXEN (2,714)
Which PALBOCICLIB Alternatives Have Lower Chronic kidney disease Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID